Search - tctmd.com

Displaying 961 - 980 of 1502

Sort: Relevancy | Date

Presentation TCT 2013

The Amaranth PLLA-based BRS (with and without Sirolimus Elution): Design, Experimental and FIH Results

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

The ABSORB III trial: Design, Goals and Enrollment Status

Presenter: Stephen Ellis

October 27, 2013

Presentation TCT 2013

The Abluminus Stent and Clinical Development Program

Presenter: Sameer Dani

October 27, 2013

Presentation TCT 2013

SYNERGY and the EVOLVE Clinical Trial Program: Minimizing the Abluminal Polymer Load while Accelerating Bioresorption

Presenter: Ian Meredith

October 27, 2013

Presentation TCT 2013

Svelte Integrated Delivery System with Enzymatic Bioabsorbable Sirolimus Coating: The DIRECT II Study and Program Update

Presenter: Stefan Verheye

October 27, 2013

Presentation TCT 2013

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

Progress with a Fully Drug-Eluting Bioresorbable Scaffold with EPC-Capture Technology

Presenter: Robert Cottone

October 27, 2013

Presentation TCT 2013

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Presenter: Richard Rapoza

October 27, 2013

Presentation TCT 2013

Perhaps, but It May Depend on Using an Optimized Bare Metal Stent Platform!

Presenter: Julio Palmaz

October 27, 2013

Presentation TCT 2013

Novel Technology for Debulking Calcific Lesions: The Japan-US CSI Study Plan

Presenter: Robert Thatcher

October 27, 2013

Presentation TCT 2013

No: In Fact, the Lack of Control Will Lead to Unpredictable Safety and Efficacy Outcomes!

Presenter: Jochen W?hrle

October 27, 2013

Presentation TCT 2013

MiStent: 2-year Randomized Trial Results from a Sirolimus-eluting Stent with a Bioabsorbable Coating

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

Metallic Stent Technology: Design Considerations

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

Presentation TCT 2013

Late Loss in Japanese and US CAD Patients: A Collaborative Advance in Understanding Transpacific Poolability

Presenter: Fumiaki Ikeno

October 27, 2013

Presentation TCT 2013

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Presenter: Peter Smits

October 27, 2013

Presentation TCT 2013

Is Normalized Vasoreactivity at and Distal to the Stent Site Likely to Translate into Improved Clinical
Outcomes?

Presenter: Raimund Erbel

October 27, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives II

Presenter: Robert-Jan van Geuns

October 27, 2013

Advertisement

The Amaranth PLLA-based BRS (with and without Sirolimus Elution): Design, Experimental and FIH Results

The ABSORB III trial: Design, Goals and Enrollment Status

The Abluminus Stent and Clinical Development Program

SYNERGY and the EVOLVE Clinical Trial Program: Minimizing the Abluminal Polymer Load while Accelerating Bioresorption

Svelte Integrated Delivery System with Enzymatic Bioabsorbable Sirolimus Coating: The DIRECT II Study and Program Update

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Progress with a Fully Drug-Eluting Bioresorbable Scaffold with EPC-Capture Technology

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Perhaps, but It May Depend on Using an Optimized Bare Metal Stent Platform!

Novel Technology for Debulking Calcific Lesions: The Japan-US CSI Study Plan

No: In Fact, the Lack of Control Will Lead to Unpredictable Safety and Efficacy Outcomes!

MiStent: 2-year Randomized Trial Results from a Sirolimus-eluting Stent with a Bioabsorbable Coating

Micro-CT Observations with ABSORB: Insights into Bifurcation Technique

Metallic Stent Technology: Design Considerations

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Latest Results from ABSORB Extend: Comparison with Xience

Late Loss in Japanese and US CAD Patients: A Collaborative Advance in Understanding Transpacific Poolability

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Is Normalized Vasoreactivity at and Distal to the Stent Site Likely to Translate into Improved Clinical
Outcomes?

Is ABSORB a Workhorse DES? Real-world Perspectives II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content